The increasing interest in effective weight management has led to considerable investigation into novel treatments. Currently, Retatrutide, a dual -action hormone and glucagon-like peptide-1 (GLP-1) receptor stimulator, has demonstrated encouraging results in clinical trials, suggesting potential for substantial weight decrease. As a result , numer